Financials in CAD. Standardized financial statements.
A compact view of how Medcolcanna Organics Inc. turns revenue into operating income and net income.
| Metric | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|
| Revenue? | $95,774 | $1,582 | $0 | $0 |
| Revenue Growth? | +5954.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $957,968 | $636 | $0 | $0 |
| Gross Profit? | -$862,194 | $946 | $0 | $0 |
| Gross Margin? | -900.2% | +59.8% | 0.0% | 0.0% |
| Operating Expenses? | $6.00M | $6.88M | $165,778 | $178,629 |
| Operating Income? | -$6.87M | -$6.88M | -$165,778 | -$178,629 |
| EBITDA? | -$6.96M | -$6.96M | -$164,135 | -$175,616 |
| Income Before Tax | -$7.43M | -$7.21M | -$168,209 | -$181,047 |
| Income Tax Expense | -$69,395 | $50,689 | -$2,431 | $0 |
| Net Income? | -$7.36M | -$7.27M | -$168,209 | -$181,047 |
| EPS? | $-0.08 | $-0.10 | $-0.00 | $-0.00 |
| Diluted EPS? | $-0.08 | $-0.10 | $-0.00 | $-0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality